Clinical Outcomes and Unique Restenosis of Calcified Nodule in Heavily Calcified Coronary Artery
Journal of Atherosclerosis and Thrombosis · 01.06.2023 · 30 (6) · 649-662
DOI: 10.5551/jat.63667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.06.2023. Verfasst von Hiroyuki Jinnouchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Drug-Eluting Stents, Atherectomy, Coronary. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University.
Zitieren
APA
Jinnouchi, H., Sakakura, K., Taniguchi, Y., Tsukui, T., Watanabe, Y., Yamamoto, K., Seguchi, M., Wada, H., & Fujita, H. (2023). Clinical Outcomes and Unique Restenosis of Calcified Nodule in Heavily Calcified Coronary Artery. Journal of Atherosclerosis and Thrombosis, 30(6), 649-662. https://doi.org/10.5551/jat.63667
Vancouver
Jinnouchi H, Sakakura K, Taniguchi Y, Tsukui T, Watanabe Y, Yamamoto K, et al. Clinical Outcomes and Unique Restenosis of Calcified Nodule in Heavily Calcified Coronary Artery. Journal of Atherosclerosis and Thrombosis. 2023;30(6):649-662. doi:10.5551/jat.63667
BibTeX
@article{Jinnouchi2023,
author = {Jinnouchi, Hiroyuki and Sakakura, Kenichi and Taniguchi, Yousuke and Tsukui, Takunori and Watanabe, Yusuke and Yamamoto, Kei and Seguchi, Masaru and Wada, Hiroshi and Fujita, Hideo},
title = {Clinical Outcomes and Unique Restenosis of Calcified Nodule in Heavily Calcified Coronary Artery},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2023},
volume = {30},
number = {6},
pages = {649--662},
doi = {10.5551/jat.63667}
}
EUVIMED